Browse By: Country ι Category ι Tag

Chronic Heart Failure Market Research Reports

Chronic Heart Failure-Pipeline Insights, 2017
DelveInsight’s, “ Chronic Heart Failure-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Heart Failure. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Heart Failure. DelveInsight’s Report also assesses the Chronic Heart
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Heart Failure Report is to understand the market and pipeline status of the drugs around the Chronic Heart Failure to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Chronic Heart Fail
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Chronic Heart Failure- Market Insights, Epidemiology and Market Forecast-2023
DelveInsight’s Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Heart Failure forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Heart Failure till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market. • Identifying patien
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Chronic Heart Failure- Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Chronic Heart Failure subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market. • Identifying prevalent patient populations as well as risk factors
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Chronic Heart Failure - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Chronic Heart Failure subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market. • Identifying prevalent patient populations as well as risk factors
Published Date: Nov 2016
Published By: DelveInsight

Price: $2750
Chronic Heart Failure - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Heart Failure – Pipeline Review, H2 2016, provides an overview of the Chronic Heart Failure (Cardiovascular) pipeline landscape. Chronic heart failure is a serious condition caused by the heart failing to pump enough blood around the body at the right pressure. The symptoms develop gradually. Common symptoms are cough, fatigue, weakness, faintness, loss of appetite; need to urinate at night, shortness of breath, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. Risk factors that contribute to heart failure are high blood pressure, coronary artery disease, heart attack, diabetes and alcohol use. Report Highlights Global Markets Direct's Pharmaceutical and
Published Date: Sep 2016
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Chronic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Heart Failure and features dormant and discontinued projects. Global Markets Direct’s report features invest
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure-Pipeline Insights, 2016
DelveInsight’s, “ Chronic Heart Failure-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Heart Failure. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Heart Failure. DelveInsight’s Report also assesses the Chronic Heart Fai
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Heart Failure Report is to understand the market and pipeline status of the drugs around the Chronic Heart Failure to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Chronic Heart Failur
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Chronic Heart Failure - Pipeline Review, H1 2015
Global Markets Directs, Chronic Heart Failure Pipeline Review, H1 2015, provides an overview of the Chronic Heart Failures therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: May 2015
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure-API Insights, 2015
DelveInsights, Chronic Heart Failure-API Insights, 2015,report provides Chronic Heart Failure drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Chronic Heart Failure. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsights report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Chronic Heart Failure drugs till 2016. The active pharmaceutical ingredients worldwide market is in continuous development from the recent yea
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Chronic Heart Failure-Pipeline Insights, 2015
SUMMARYDelveInsights, Chronic Heart Failure-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Chronic Heart Failure. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Chronic Heart Failure. The report provides information on the therapeutic development based on the Chronic Heart Failure providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsights Report is assessing the Chronic Heart Failure therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsights Reports are also highlighting the disco
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Chronic Heart Failure Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Chronic Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Chronic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDa
Published Date: Aug 2014
Published By: GlobalData

Price: $2500
Chronic Heart Failure-Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days.  DelveInsights, Chronic Heart Failure-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chronic Heart Failure. This report provides information on the therapeutic development based on the Chronic Heart Failure dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic develo
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Chronic Heart Failure Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
The Report will be Dispatched in 3 Working days.  DelveInsights, Chronic Heart Failure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent
Published Date: Aug 2014
Published By: DelveInsight

Price: $2000
Chronic Heart Failure - Pipeline Review, H2 2014
Chronic Heart Failure - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chronic Heart Failure - Pipeline Review, H2 2014, provides an overview of the Chronic Heart Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H1 2014
Chronic Heart Failure - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Chronic Heart Failure - Pipeline Review, H1 2014, provides an overview of the Chronic Heart Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H2 2013
Global Markets Directs, Chronic Heart Failure - Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Heart Failure. Chronic Heart Failure - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Note*: Certain section
Published Date: Jul 2013
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Current and Future Players
GlobalData has released its pharma report, Chronic Heart Failure Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Chronic heart failure (CHF) Market. The report identifies and analyses the key companies shaping and driving the global CHF market. The report provides insight into the competitive CHF landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts. Scope Investigation of current and future market competition for CHF  Competitor assessment  Coverage of key market players and company profiles includin
Published Date: Jun 2013
Published By: GlobalData

Price: $2995
PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022
GlobalData has released its new Country report, PharmaPoint: Chronic Heart Failure US Drug Forecast and Market Analysis to 2022. The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose market exclusivity during the next few years. GlobalData predicts that the major global barriers that will play a crucial role in narrowing the global growth of the CHF market over the forecast period include the sparsely populated CHF pipeline and an increasing number of generic competitors in a market that is already heavily laden with generic drugs. The US is the largest CHF market due to its having the highest CHF population and high drug prices. Over the forecast period, the major driver for growth i
Published Date: Jun 2013
Published By: GlobalData

Price: $4995

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top